Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C

Direct‐Acting Antiviral Treatment Use Remains Low Among Florida Medicaid Beneficiaries With Chronic Hepatitis C

Medicaid prior authorization (PA) policies for treatment of hepatitis C virus (HCV) with direct‐acting antiviral (DAA) therapy are changing. We aimed to evaluate effects of changes in PA requirements on treatment uptake and to determine the factors associated with DAA treatment among Florida Medicai...

Deskribapen osoa

Xehetasun bibliografikoak
Egile Nagusiak: Haesuk Park, Hyun Jin Song, Xinyi Jiang, Linda Henry, Robert L. Cook, David R. Nelson
Formatua: Artikulua
Hizkuntza:English
Argitaratua: Wolters Kluwer Health/LWW 2021-02-01
Saila:Hepatology Communications
Sarrera elektronikoa:https://doi.org/10.1002/hep4.1634

Internet

https://doi.org/10.1002/hep4.1634

Antzeko izenburuak